Rocket Lab Neutron delay could cost $110 million quarterly
A delay in the launch of Rocket Lab's Neutron rocket would extend the company's period of negative free cash flow by approximately $110 million each quarter. Management stated on an August 10 call that the window for a launch by the end of 2026 is narrowing, a timeline critical to the stock's current valuation at 52.6 times sales, compared with 3.1 for the S&P 500.
A delay in the launch of Rocket Lab's Neutron rocket would extend the company's period of negative free cash flow by approximately $110 million each quarter. Management stated on an August 10 call that the window for a launch by the end of 2026 is narrowing, a timeline critical to the stock's current valuation at 52.6 times sales, compared with 3.1 for the S&P 500.
Rocket Lab reported a free cash flow outflow of $110.1 million in the second quarter, a figure management expected to remain elevated in the third quarter. The company holds roughly $2.4 billion in cash and securities as of the end of the second quarter. At the current burn rate, each quarter of delay would consume less than 5% of that total. However, a significant portion of the cash is already allocated; management noted that the $1.08 billion raised through share sales in the second quarter is partly earmarked for acquisitions, including the announced purchase of Iridium. Despite these commitments, a delay appears manageable for the company rather than existential.
The financial impact of a delay extends to the timeline for reaching profitability. Management targets positive adjusted EBITDA shortly after Neutron transitions to regular commercial service. Reaching positive cash flow is estimated to take an additional 18 to 24 months following that milestone. Over the last twelve months, Rocket Lab spent $0.4 billion more in cash than it collected. Shareholders may face a longer wait for returns; during the 2022 inflation shock, Rocket Lab stock fell 70%, while the S&P 500 declined by 24%.
Current revenue for Rocket Lab is driven primarily by its Space Systems segment, which includes satellite manufacturing. This segment generated $189.5 million of the $234 million total revenue reported for the second quarter. The company's Electron rocket also continues to secure contracts, including a 20-launch agreement signed with Synspective on September 30, which marks its largest commercial Electron deal to date.
Rocket Lab ended the second quarter with approximately $2.36 billion in backlog, representing work signed but not yet delivered. Management expects about $1.1 billion of this backlog to convert to revenue within the next twelve months, exceeding the $0.8 billion reported over the prior year. Launches account for roughly 40% of this backlog, and recent bookings include contracts for Neutron.
The company has narrowed its operating losses, with the operating loss standing at 29% of revenue over the last twelve months, down from 44% a year earlier.
Investors will look to specific indicators for signs of a Neutron delay. Management targets delivery of the vehicle to the launch pad in the fourth quarter of 2026, followed by stage testing where engines fire on a fully fueled vehicle for the first time. Financial confirmation will arrive in the third-quarter report, where management has guided revenue of $250 million to $265 million and an adjusted EBITDA loss of $17 million to $23 million. Free cash flow in that report will serve as the primary metric for assessing the cost of any waiting period.